We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Devicemakers Can Avoid Blame for Inflated Costs With New Competitive Strategies
Devicemakers Can Avoid Blame for Inflated Costs With New Competitive Strategies
July 28, 2006
Device and diagnostics makers can avoid being blamed for inflated healthcare costs by focusing on competitive strategies that add value to their products, experts say.